Efficacy and Tolerability of Telmisartan/Amlodipine + Hydrochlorothiazide Versus Telmisartan/Amlodipine Combination Therapy for Essential Hypertension Uncontrolled With Telmisartan/Amlodipine: The Phase III, Multicenter, Randomized, Double-blind TAHYTI Study

Clinical Therapeutics

Volumn 40, Issue 1, 2018, Pages 50-63.e3

  Sung, Ki Chul ^a,b   Oh, Yong Seog ^c   Cha, Dong Hun ^d   Hong, Soon Jun ^e   Won, Kyung Heon ^f   Yoo, Ki Dong ^g   Rha, Seung Woon ^h   Ahn, Young Keun ⁱ   Ahn, Jeong Cheon ^j   Jang, Ji Yong ^k   Hong, Tack Jong ^l   Cho, Sang Kyoon ^m   Park, Sang Ho ⁿ   Hyon, Min Su ^o   Nam, Chang Wook ^p   Chae, In Ho ^q   Yoo, Byung Su ^r   Song, Jong Min ^s   Jeong, Jin Ok ^t   Yoon, Young Won ^u   Kim, Byung Soo ^v   Yang, Tae Hyun ^w   Cho, Deok Kyu ^x   Kim, Sang Hyun ^y   Choi, Yu Jeong ^z   Ahn, Ji Hun ^aa   Jeon, Dong Woon ^ab   Kim, Hyo Soo ^a,b   more..

^a Sungkyunkwan University   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c The Catholic University of Korea   (South Korea)

^d CHA University   (South Korea)

^e College of Medicine   (South Korea)

^f Seoul Medical Center   (South Korea)

^g The Catholic University of Korea   (South Korea)

^h Korea University College of Medicine   (South Korea)

ⁱ Chonnam National University Medical School   (South Korea)

^j Korea University   (South Korea)

^k Konkuk University Hospital   (South Korea)

^l Pusan National University School of Medicine   (South Korea)

^m Bundang Jesaeng Hospital   (South Korea)

ⁿ Department of Urology   (South Korea)

^o Soonchunhyang University College of Medicine   (South Korea)

^p Dongsan Medical Center   (South Korea)

^q Seoul National University Bundang Hospital   (South Korea)

^r Wonju Severance Christian Hospital   (South Korea)

^s Asan Medical Center   (South Korea)

^t Chungnam National University College of Medicine   (South Korea)

^u Yonsei University College of Medicine   (South Korea)

^v Dae Dong Hospital   (South Korea)

^w Inje University College of Medicine   (South Korea)

^x Seonam University of Medicine Myongji Hospital   (South Korea)

^y Seoul National University Boramae Hospital   (South Korea)

^z Eulji University   (South Korea)

^aa Gumi University   (South Korea)

^ab National Health Insurance Corporation   (South Korea)

more..

Author keywords

amlodipine; blood pressure control; hydrochlorothiazide; hypertension; telmisartan; triple combination

Indexed keywords

AMLODIPINE PLUS TELMISARTAN; HYDROCHLOROTHIAZIDE; AMLODIPINE; ANTIHYPERTENSIVE AGENT; BENZIMIDAZOLE DERIVATIVE; BENZOIC ACID DERIVATIVE; TELMISARTAN AMLODIPINE COMBINATION;

ADULT; ARTICLE; BACKACHE; CHRONIC KIDNEY FAILURE; COMBINATION DRUG THERAPY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE PREDISPOSITION; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ELECTROCARDIOGRAM; ESSENTIAL HYPERTENSION; FAINTNESS; FEMALE; HEADACHE; HUMAN; INTERVERTEBRAL DISC PROTRUSION; INTERVERTEBRAL DISK DISEASE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MONOTHERAPY; MULTICENTER STUDY; PATIENT COMPLIANCE; PHASE 3 CLINICAL TRIAL; PHYSICAL EXAMINATION; RANDOMIZED CONTROLLED TRIAL; RETINA HEMORRHAGE; SYSTOLIC BLOOD PRESSURE; VITAL SIGN; AGED; BLOOD PRESSURE; CHEMICALLY INDUCED; CLINICAL TRIAL; DRUG COMBINATION; DRUG EFFECT; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; AGED; AMLODIPINE; ANTIHYPERTENSIVE AGENTS; BENZIMIDAZOLES; BENZOATES; BLOOD PRESSURE; DIZZINESS; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; ESSENTIAL HYPERTENSION; FEMALE; HEADACHE; HUMANS; HYDROCHLOROTHIAZIDE; MALE; MIDDLE AGED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 85040029234     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2017.11.006     Document Type: Article

References (31)

1. Korean National Health and Nutrition Examination Survey (KNHANES). http://knhanes.cdc.go.kr/knhanes/main.do. Accessed on: December 6, 2017.
2. Shin, J., Park, J.B., Kim, K.I., et al., for the Guideline Committee of the Korean Society of Hypertension. 2013 Korean Society of Hypertension guidelines for the management of hypertension: part I—epidemiology and diagnosis of hypertension. Clin Hypertens, 21, 2015, 1.
3. Gu, Q., Burt, V.L., Dillon, C.F., et al. Trends in antihypertensive medication use and blood pressure control among United States adults with hypertension: the National Health and Nutrition Examination Survey, 2001 to 2010. Circulation 126 (2012), 2105–2114.
4. Kearney, P.M., Whelton, M., Reynolds, K., et al. Global burden of hypertension: analysis of worldwide data. Lancet 365 (2005), 217–223.
5. Wald, D.S., Law, M., Morris, J.K., et al. Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials. Am J Med 122 (2009), 290–300.
6. Ohishi, M., Kawai, T., Hayashi, N., et al. Effect of tablets with a combination of telmisartan and amlodipine on patients with hypertension: the Cotalo study. Hypertens Res 36 (2013), 620–626.
7. James, P.A., Oparil, S., Carter, B.L., et al. Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014:311 (2014), 507–520.
8. Mancia, G., Fagard, R., Narkiewicz, K., et al., for the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). 2013 ESH/ESC guidelines for the management of arterial hypertension. Eur Heart J 34 (2013), 2159–2219.
9. National Institute for Health and Clinical Excellence. Hypertension in Adults: Diagnosis and management. www.nice.org.uk/guidance/CG127. Accessed date: December 6, 2017.
10. National Clinical Guideline Centre (UK). Hypertension: The Clinical Management of Primary Hypertension in Adults: Update of Clinical Guidelines 18 and 34. 2011, Royal College of Physicians (UK), London, UK NICE Clinical Guidelines no. 127.
11. Noh, Y.H., Lim, H.S., Kim, M.J., et al. Pharmacokinetic interaction of telmisartan with s-amlodipine: an open-label, two-period crossover study in healthy Korean male volunteers. Clin Ther 34 (2012), 1625–1635.
12. Chrysant, S.G., The role of Angiotensin receptor blocker and calcium channel blocker combination therapy in treating hypertension: focus on recent studies. Am J Cardiovasc Drugs 10 (2010), 315–320.
13. Ishimitsu, T., Numabe, A., Masuda, T., et al. Angiotensin-II receptor antagonist combined with calcium channel blocker or diuretic for essential hypertension. Hypertens Res 32 (2009), 962–968.
14. Ram, C.V., Antihypertensive efficacy of angiotensin receptor blockers in combination with hydrochlorothiazide: a review of the factorial-design studies. J Clin Hypertens (Greenwich) 6 (2004), 569–577.
15. Ma, L., Wang, W., Zhao, Y., et al. Combination of amlodipine plus angiotensin receptor blocker or diuretics in high-risk hypertensive patients: a 96-week efficacy and safety study. Am J Cardiovasc Drugs 12 (2012), 137–142.
16. Lacourcière, Y., Neutel, J.M., Schumacher, H., et al. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials. Clin Ther 27 (2005), 1795–1805.
17. Higaki, J., Komuro, I., Shiki, K., et al. Effect of hydrochlorothiazide in addition to telmisartan/amlodipine combination for treating hypertensive patients uncontrolled with telmisartan/amlodipine: a randomized, double-blind study. Hypertens Res 40 (2017), 251–258.
18. Lacourcière, Y., Martin, K., Comparison of fixed-dose combination of 40 mg telmisartan plus 12.5mg hydrochlorothiazide with 40 mg telmisartan in the control of mild to moderate hypertension. Am J Ther 9 (2002), 111–117.
19. Lacourcière, Y., Tytus, R., O'Keefe, D., et al. Efficacy and tolerability of a fixed-dose combination of telmisartan plus hydrochlorothiazide in patients uncontrolled with telmisartan monotherapy. J Hum Hypertens 15 (2001), 763–770.
20. Kizilirmak, P., Berktas, M., Uresin, Y., et al. The efficacy and safety of triple vs dual combination of angiotensin II receptor blocker and calcium channel blocker and diuretic: a systematic review and meta-analysis. J Clin Hypertens (Greenwich) 15 (2013), 193–200.
21. Chow, C.K., Teo, K.K., Rangarajan, S., et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA 310 (2013), 959–968.
22. Jamerson, K., Weber, M.A., Bakris, G.L., et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 359 (2008), 2417–2428.
23. Düsing, R., Waeber, B., Destro, M., et al. Triple-combination therapy in the treatment of hypertension: a review of the evidence. J Hum Hypertens 31 (2017), 501–510.
24. Chow, C.K., Thakkar, J., Bennett, A., et al. Quarter-dose quadruple combination therapy for initial treatment of hypertension: placebo-controlled, crossover, randomised trial and systematic review. Lancet 389 (2017), 1035–1042.
25. Calhoun, D.A., Lacourcière, Y., Chiang, Y.T., et al. Triple antihypertensive therapy with amlodipine, valsartan, and hydrochlorothiazide: a randomized clinical trial. Hypertension 54 (2009), 32–39.
26. Oparil, S., Melino, M., Lee, J., et al. Triple therapy with olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide in adult patients with hypertension: the TRINITY multicenter, randomized, double-blind, 12-week, parallel-group study. Clin Ther 32 (2010), 1252–1269.
27. Calhoun, D.A., Crikelair, N.A., Yen, J., et al. Amlodipine/valsartan/hydrochlorothiazide triple combination therapy in moderate/severe hypertension: secondary analyses evaluating efficacy and safety. Adv Ther 26 (2009), 1012–1023.
28. Kim, S., Shin, D.W., Yun, J.M., et al. Medication adherence and the risk of cardiovascular mortality and hospitalization among patients with newly prescribed antihypertensive medications. Hypertension 67 (2016), 506–512.
29. Neutel, J.M., The role of combination therapy in the management of hypertension. Nephrol Dial Transplant 21 (2006), 1469–1473.
30. Elijovich, F., Laffer, C., A role for single-pill triple therapy in hypertension. Ther Adv Cardiovasc Dis 3 (2009), 231–240.
31. Black, H.R., Triple fixed-dose combination therapy: back to the past. Hypertension 54 (2009), 19–22.